Factory Direct High Purity Estriol (CAS: 50-27-1) Estratriol

Model NO.: 3000
CAS No.: 50-27-1
Ecnecs No.: 200-022-2
Mf: C18h24o3
MW: 288.3814
Density: 1.255g/cm3
Melting Point: 281-282o C
Boiling Point: 469 ° C at 760 Mmhg
Refractive Index: 1.624
Flash Point: 220.8 ° C
Trademark: YIJING
Transport Package: According to Every Customers′s Requirements
Specification: SGS GMP ISO
Origin: Shanghai
HS Code: 2616900009
Model NO.: 3000
CAS No.: 50-27-1
Ecnecs No.: 200-022-2
Mf: C18h24o3
MW: 288.3814
Density: 1.255g/cm3
Melting Point: 281-282o C
Boiling Point: 469 ° C at 760 Mmhg
Refractive Index: 1.624
Flash Point: 220.8 ° C
Trademark: YIJING
Transport Package: According to Every Customers′s Requirements
Specification: SGS GMP ISO
Origin: Shanghai
HS Code: 2616900009
Estriol
 
Synonyms: Oestriol; 1, 3, 5(10)-Estratriene-3, 16a, 17b-triol
CAS No.: 50-27-1
ECNECS No.: 200-022-2
MF: C18H24O3
MW: 288.3814
Purity: 99%min
Density: 1.255g/cm3
Melting Point: 281-282º C
Boiling Point: 469 ° C at 760 mmHg
Refractive Index: 1.624
Flash Point: 220.8 ° C
Appearance: White crystalline powder
Grade: Pharmaceutical Grade
Storage: Shading, confined preservation
Lead time: Within 12 hours upon receipt of payment
Delivery: EMS, DHL, TNT, FedEx, UPS
Usage: A metabolite of Estradiol. An estrogenic metabolite considerably less potent than the hormone Estradiol. Pharmaceutical material, Steroid hormone, estrogen.
 
Description: 
 
Estriol can be a weak or strong estrogen depending on if it is given acutely or chronically when given to immature animals, but is an antagonist when given in combination with estradiol. 
 
Estriol may play a role in the development of breast cancer, but based on in vitro research, does appear to act as an antagonist to the G-protein coupled estrogen receptor. Though estriol is used as part of the primarily North American phenomenon of bioidentical hormone replacement therapy, it is not approved for use by the FDAor Health Canada. 
 
Though initial research in the 1970s suggested it could be used therapeutically as an estrogen, subsequent research failed to confirm this hypothesis.
 
In pregnant women with multiple sclerosis, estriol reduces the disease's symptoms noticeably, according to researchers at UCLA's Geffen Medical School. 
 
Estriol can be a weak or strong estrogen depending on if it is given acutely or chronically when given to immature animals, but is an antagonist when given in combination with estradiol. 
 
Estriol may play a role in the development of breast cancer, but based on in vitro research, does appear to act as an antagonist to the G-protein coupled estrogen receptor. Though estriol is used as part of the primarily North American phenomenon of bioidentical hormone replacement therapy, it is not approved for use by the FDAor Health Canada. 
 
Though initial research in the 1970s suggested it could be used therapeutically as an estrogen, subsequent research failed to confirm this hypothesis.
 
  Estriol
 
Synonyms: Oestriol; 1, 3, 5(10)-Estratriene-3, 16a, 17b-triol
CAS No.: 50-27-1
ECNECS No.: 200-022-2
MF: C18H24O3
MW: 288.3814
Purity: 99%min
Density: 1.255g/cm3
Melting Point: 281-282º C
Boiling Point: 469 ° C at 760 mmHg
Refractive Index: 1.624
Flash Point: 220.8 ° C
Appearance: White crystalline powder
Grade: Pharmaceutical Grade
Storage: Shading, confined preservation
Lead time: Within 12 hours upon receipt of payment
Delivery: EMS, DHL, TNT, FedEx, UPS
Usage: A metabolite of Estradiol. An estrogenic metabolite considerably less potent than the hormone Estradiol. Pharmaceutical material, Steroid hormone, estrogen.
 
Description: 
 
Estriol can be a weak or strong estrogen depending on if it is given acutely or chronically when given to immature animals, but is an antagonist when given in combination with estradiol. 
 
Estriol may play a role in the development of breast cancer, but based on in vitro research, does appear to act as an antagonist to the G-protein coupled estrogen receptor. Though estriol is used as part of the primarily North American phenomenon of bioidentical hormone replacement therapy, it is not approved for use by the FDAor Health Canada. 
 
Though initial research in the 1970s suggested it could be used therapeutically as an estrogen, subsequent research failed to confirm this hypothesis.
 
In pregnant women with multiple sclerosis, estriol reduces the disease's symptoms noticeably, according to researchers at UCLA's Geffen Medical School. 
 
Estriol can be a weak or strong estrogen depending on if it is given acutely or chronically when given to immature animals, but is an antagonist when given in combination with estradiol. 
 
Estriol may play a role in the development of breast cancer, but based on in vitro research, does appear to act as an antagonist to the G-protein coupled estrogen receptor. Though estriol is used as part of the primarily North American phenomenon of bioidentical hormone replacement therapy, it is not approved for use by the FDAor Health Canada. 
 
Though initial research in the 1970s suggested it could be used therapeutically as an estrogen, subsequent research failed to confirm this hypothesis.
 
Â